During a press conference held on October 13, PSRM President Dr. Quincy P. Raya and Dr. Daryl Joel C. Dumdum met with members ...

Under the Advanced Regenerative Medicine treatment plan launched in September, ViGenCell's immune cell therapy VT-EBV-N will ...

Before joining Alliance Orthopedics, Dr. Cartagena spent two years working in a high-volume private practice setting, ...

Custom Health's existing commercial program with BKC Pain Specialists & Regenerative Medicine Clinic in Ohio is demonstrating early results through the integration of in-home medication technology, ...

Adia Med, Inc. (OTCQB: ADIA) today announced that its Chief Executive Officer, Larry Powalisz, purchased a 7% economic interest in Adia Labs LLC for $350,000 in cash. Under the completed Membership ...

A new USC-led study links abnormal immature astroglia, star-shaped cells that support brain function, to lower fluid ...

Autologous Cutaneous Multicellular Units in Non-Healing Wagner 1 Diabetic Foot Ulcers: Results of the Phase 3 COVER DFUS II Trial” honored with ...

Buck Institute’s Eric Verdin joins clinic leaders to tackle the ‘luxury diagnostic’ trap and the push for standardized care.

From polynucleotides to exosomes, explore six tissue repair technologies, their potential benefits & the limits of current ...

Xylyx Bio, Inc., a regenerative medicine company developing bioengineered technologies for organ transplantation, tissue ...

Custom Health Holdings Inc (TSX:CHLT) said early results from its commercial program with BKC Pain Specialists & Regenerative ...

A sold-out Kyoto symposium brought together scientists, clinicians, and innovators reviewing 20 years of iPSC research across development models, disease modeling, genetic stability, and clinical ...